Combination chemotherapy as induction therapy for advanced resectable head and neck cancer

Journal of Surgical Oncology

Volumn 59, Issue 2, 1995, Pages 80-85

  Maipang, Tanaphon ^a   Maipang, Matinee ^a   Geater, Alan ^a   Panjapiyakul, Chingyiam ^a   Watanaarepornchai, Somchai ^a   Punperk, Supaporn ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

chemotherapy; head and neck cancer; squamous cell carcinoma

Indexed keywords

BLEOMYCIN; CISPLATIN; DEXAMETHASONE; FOLINIC ACID; METHOTREXATE; METOCLOPRAMIDE; VINBLASTINE; VINCRISTINE;

ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; NAUSEA; NEPHROTOXICITY; PHARYNX CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHOTREXATE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0029079437     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.2930590203     Document Type: Article

References (24)

1. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous‐cell carcinoma of the head and neck
2. Improved complete response rate and survival in advanced head and neck cancer after three‐course induction therapy with 120‐hour 5‐FU infusion and cisplatin
3. Treatment of squamous cell carcinoma of the head and neck with cisplatin and 5‐fluorouracil
4. Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer
5. Long‐term follow‐up of chemotherapy in advanced head and neck cancer
6. Combination chemotherapy of head and neck cancer
7. A randomized trial of the combination of cisplatinum, oncovin and bleomycin (COB) vs methotrexate in patients with advanced squamous cell carcinoma of the head and neck
8. A randomized prospective comparison of intermittent methotrexate with leucovorin and a methotrexate combination in head and neck cancer
9. The chemotherapy of head and neck cancer
10. A randomized propective comparison of methotrexate with a combination of methotrexate, bleomycin and cisplatin in head and neck cancer
11. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM)
12. Head and neck cancer: Chemotherapy concepts
13. Induction chemotherapy for advanced head and neck cancer
14. Chemotherapy of head and neck cancer
15. Superior complete clinical response and survival rates with initial bolus cis‐platinum and 120 hour 5 FU infusion before definitive therapy in patients with locally advanced head and neck cancer
16. Induction chemotherapy in advanced head and neck cancer
17. The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies
18. Combination of cisplatinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck
19. Combination chemotherapy with vinblastine, bleomycin and Cis‐diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck
20. Adjuvant chemotherapy in advanced head and neck cancer: An update
21. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimen
22. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx
23. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group